cartilage matrix
Biologicalexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2012 (NCT02770209)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Mechanism of action
- Unspecified targetSupplementation
cartillage
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cartilage matrix
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06800820 | N/A | Jan 23, 2025 | Clinic'n'Cell, Symrise Group |
| NCT06897111 | Phase 1/Phase 2 (Phase 2) | Jun 17, 2024 | Vanarix SA |
| NCT06897098 | Phase 1 | Jun 10, 2022 | Vanarix SA |
| NCT02770209 | N/A | Feb 1, 2012 | People's Liberation Army of China |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vanarix SA | For profit | 2 | 2 | 2 | 2022 |
| Clinic'n'Cell | For profit | 1 | 0 | 1 | 2025 |
| People's Liberation Army of China | Government | 1 | 1 | 1 | 2012 |
| Symrise Group | For profit | 1 | 1 | 1 | 2025 |
4 organizations
Page 1 / 1